☰ Sidebar
Voting period for this idea type has passed

SXSW 2019

Re-imagining Cannabis with Lab-Verified Data

With thousands of cannabis strains and products, consumers are challenged with choosing for their individual needs. Dispensaries and businesses are challenged with organizing and recommending products. Doing this effectively requires accurate laboratory measurements of THC, CBD, and terpene profiles. However, not all lab data is trustworthy.

Leafly is partnering with reliable labs to evolve the strains classification system through sophisticated cannabis research and testing, helping consumers and businesses refine sale and consumption. A complex purchasing experience is simplified for consumers, retailers and producer-processors can effectively curate product lines, and researchers, regulators, and other industry professionals can apply accurate data science to the cannabis space.

Share this idea

Related Media

Additional Supporting Materials

Takeaways

  1. Understanding THC, CBD and terpene profiles, which are essential to predicting the effects of cannabis products, requires valid lab testing data.
  2. Accurate lab data can be used to organize cannabis strains and products into distinct groups based on their cannabinoid and terpene profiles.
  3. Leafly’s data science and verified lab testing will allow cannabis’ overwhelming product landscape to be simplified in exciting ways.

Speakers

  • Nick Jikomes, Principal Research Scientist, Leafly

Organizer

Renee Beck, Public Relations Lead, Leafly

Meta Information:

  • Event: SXSW
  • Format: Solo
  • Track: Cannabusiness
  • Level: Advanced
Show me another idea

Add Comments

comments powered by Disqus

SXSW reserves the right to restrict access to or availability of comments related to PanelPicker proposals that it considers objectionable.